billHR10127Event Thursday, August 20, 2026Analyzed

To prohibit the use of Federal funds to conduct, support, or fund research that studies the effects of gender-related medical treatment, and for other purposes.

Neutral

Summary

HR10127, introduced in the House on August 20, 2026, would prohibit federal funds for research on gender-related medical treatments. It is in early legislative stages, referred to committee with no cosponsors. The bill has no direct market impact as it does not authorize or appropriate funds, and its future is highly uncertain.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR10127 is a symbolic early-stage bill with no funding or cosponsors.
  • 2.No direct market impact; healthcare sector impact is speculative.
  • 3.Investors should monitor for committee action but expect no near-term effect.

Market Implications

The bill has no direct market implications. Healthcare companies are not affected because the bill does not alter private sector operations or funding. If the bill were to advance, it could reduce federal research funding, but this is too speculative to drive investment decisions.

Full Analysis

HR10127 was introduced in the House on August 20, 2026, and referred to the House Committee on Energy and Commerce. It is an early-stage bill with no cosponsors and no committee action beyond referral. The bill would prohibit the use of federal funds for research on gender-related medical treatments, but it does not specify any funding amounts or mechanisms. As an authorization-type bill, it would only set policy; any actual spending changes would require separate appropriations. Given the early stage and lack of momentum, the bill is unlikely to advance in the near term. The healthcare sector could be affected if the bill were to pass, potentially reducing federal funding for certain research, but this is speculative. No specific public companies are directly implicated, as the bill targets federal research funding rather than private sector operations. The legislative path ahead includes committee hearings, markup, and floor votes in both chambers, which are uncertain.

Key Legislators

Rep. Mace, Nancy [R-SC-1]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →